Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: We investigated the mid-term systolic ventricular response to transcatheter pulmonary valve replacement (TPVR) in patients with repaired tetralogy of Fallot (TOF) and pulmonary stenosis (PS), pulmonary regurgitation (PR) and a MIXED subgroup that included patients with both PR and PS.

Methods: We included patients with repaired TOF with PS, atresia and absent pulmonary valve underwent TPVR (2007-2011) and followed at BCH until 2021. We compared their serial clinical, echo imaging as well as cardiopulmonary exercise test data among PS, PR and MIXED subgroups.

Results: In 63 patients (20.8 years of age) the median early follow-up (FU) after TPVR was 6.2 months, and mid-term - 2.8 years. At baseline, the PR (n = 23) had lower LV EF, mass z-scores and global longitudinal strain (GLS) and the percent predicted peak O2 pulse than PS (n = 16) and those in the MIXED (n = 24) subgroups. BiV GLS improvement from baseline to early and to midterm FU occurred for all subgroups except for the LV GLS in the MIXED, which showed improvement from baseline to early follow-up. PR subgroup's LV GLS had gradual improvement, it remained lower than in PS and MIXED. No significant difference in exercise parameters were seen following TPVR. Freedom from reintervention at 10 years of FU was only 13.4 %.

Conclusions: Patients with PR had lower LV systolic function and exercise capacity than those with PS or MIXED prior TPVR with normalization of systolic function midterm in all thereafter. Overall, about 1 in 8 remained free from reintervention after 10 years.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2025.133305DOI Listing

Publication Analysis

Top Keywords

pulmonary valve
12
tetralogy fallot
8
transcatheter pulmonary
8
valve replacement
8
patients repaired
8
included patients
8
early follow-up
8
improvement baseline
8
baseline early
8
reintervention 10 years
8

Similar Publications

Objectives: To quantify intraoperative pulmonary arterial catheter (PAC) use during cardiac surgery and identify hospital-, anesthesiologist-, and patient-level factors associated with PAC utilization.

Design: A cross-sectional, observational study using generalized logistic mixed models to examine variations in PAC use.

Setting: Fifty-three US academic hospitals participating in the Multicenter Perioperative Outcomes Group (MPOG) national registry PARTICIPANTS: 145,343 adult patients undergoing cardiac surgery between January 1, 2016, and December 31, 2022.

View Article and Find Full Text PDF

Background: Pulmonary hypertension is a contraindication to correction of tricuspid regurgitation.

Case Summary: A 75-year-old Italian woman with previous episodes of right heart failure was diagnosed with World Health Organization (WHO) functional class IV pulmonary arterial hypertension (PAH) complicated by torrential tricuspid regurgitation. After 6 months of treatment with diuretic agents, macitentan, and tadalafil, she improved to WHO functional class III, with a pulmonary vascular resistance (PVR) decreasing from 5.

View Article and Find Full Text PDF

Background: The effectiveness of ethanol infusion of the vein of Marshall (EIVOM) for persistent atrial fibrillation (AF) in patients with mitral valve replacement (MVR) remains to be determined.

Objectives: This study investigated the effectiveness and safety of EIVOM in catheter ablation of persistent AF in patients with MVR.

Methods: This is a retrospective case-control study.

View Article and Find Full Text PDF

Spanish cardiac catheterization and coronary intervention registry. 34 official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2024).

Rev Esp Cardiol (Engl Ed)

September 2025

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, España; Servicio de Cardiología, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, España.

Introduction And Objectives: This report presents the 2024 activity data from the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC).

Methods: All interventional cardiology laboratories in Spain were invited to complete an online survey. Data analysis was conducted by an external company and then reviewed and presented by the ACI-SEC board.

View Article and Find Full Text PDF

Background: In transcatheter aortic valve replacement (TAVR), there is a notable "diabetes discrepancy", where worse/better/similar outcomes were all found for patients with diabetes mellitus (DM). Such divergent findings pose a challenge for clinicians to accurately assess the risks for DM patients undergoing TAVR. We hypothesized the presence of chronic complications could be linked to worse post-TAVR outcomes in DM patients.

View Article and Find Full Text PDF